These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15109461)

  • 1. Role of Fas-FasL in insulitis in nonobese diabetic mouse.
    Cao JY; Wang H
    Chin Med J (Engl); 2004 Apr; 117(4):615-7. PubMed ID: 15109461
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
    Thomas HE; Darwiche R; Corbett JA; Kay TW
    J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans.
    Wang H; Li Y; Sun Q; Yang G
    Chin Med J (Engl); 2000 May; 113(5):433-6. PubMed ID: 11776099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
    Augstein P; Bahr J; Wachlin G; Heinke P; Berg S; Salzsieder E; Harrison LC
    J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMV-hFasL transgenic mice are sensitive to low doses of streptozotocin-induced type I diabetes mellitus.
    Lin B; Zhang ZL; Yu LY; Guo LH
    Acta Pharmacol Sin; 2003 Dec; 24(12):1199-204. PubMed ID: 14653944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A defect in central tolerance in NOD mice.
    Kishimoto H; Sprent J
    Nat Immunol; 2001 Nov; 2(11):1025-31. PubMed ID: 11668341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of Fas, FasL in NOD insulitis].
    Cao JY; Wang H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):486-90. PubMed ID: 12905770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice.
    Augstein P; Heinke P; Salzsieder E; Berg S; Rettig R; Salzsieder C; Harrison LC
    Endocrinology; 2004 Jun; 145(6):2747-52. PubMed ID: 15033908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes.
    Apostolou I; Hao Z; Rajewsky K; von Boehmer H
    J Exp Med; 2003 Oct; 198(7):1103-6. PubMed ID: 14530378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus.
    Moriwaki M; Itoh N; Miyagawa J; Yamamoto K; Imagawa A; Yamagata K; Iwahashi H; Nakajima H; Namba M; Nagata S; Hanafusa T; Matsuzawa Y
    Diabetologia; 1999 Nov; 42(11):1332-40. PubMed ID: 10550417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
    Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B
    J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
    Jiang TJ; Zhou ZG; Su H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
    Qin HY; Chaturvedi P; Singh B
    Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Fas/FasL system in the pathogenesis of autoimmune diseases and Wilson's disease.
    Stassi G; Di Felice V; Todaro M; Cappello F; Zummo G; Farina F; Trucco M; De Maria R
    Arch Immunol Ther Exp (Warsz); 1999; 47(3):129-33. PubMed ID: 10470438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of Fas to diabetes development.
    Savinov AY; Tcherepanov A; Green EA; Flavell RA; Chervonsky AV
    Proc Natl Acad Sci U S A; 2003 Jan; 100(2):628-32. PubMed ID: 12525697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [FasL-Fas/APO-1 (CD95) system].
    Sun CK; Ju G
    Sheng Li Ke Xue Jin Zhan; 1997 Apr; 28(2):136-8. PubMed ID: 11038707
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of a microsatellite in FASL to type II diabetes and of the FAS-670G>A genotype to insulin resistance.
    Nolsøe RL; Hamid YH; Pociot F; Paulsen S; Andersen KM; Borch-Johnsen K; Drivsholm T; Hansen T; Pedersen O; Mandrup-Poulsen T
    Genes Immun; 2006 Jun; 7(4):316-21. PubMed ID: 16691186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
    Kim S; Kim KA; Hwang DY; Lee TH; Kayagaki N; Yagita H; Lee MS
    J Immunol; 2000 Mar; 164(6):2931-6. PubMed ID: 10706679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes.
    Kim YH; Kim S; Kim KA; Yagita H; Kayagaki N; Kim KW; Lee MS
    Eur J Immunol; 1999 Feb; 29(2):455-65. PubMed ID: 10064061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Membrane protein Fas/FasL system in viral infections].
    Ma BJ; Hang CS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):94-7. PubMed ID: 12526314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.